instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
Questions about whether the NHS can survive in its present form are the subject of a long-running British debate, given an aging population and increased costs due to advances in medicine and surgery. Following is a timeline of key events spanning its history. Health minister Aneurin Bevan launches the tax-funded NHS to bring medical services together and provide free healthcare to all. Polio and diphtheria vaccines become available to children under 15, leading to a major fall of cases in both diseases. The Mental Health Act recognizes for the first time that patients with mental health issues should be treated the same as those with other types of illnesses. Kick-starting the “Swinging Sixties”, the contraceptive pill is made widely available amid a major movement for women’s liberation. The number of women on the pill rises from around 50,000 in 1962 to 1 million in 1969. The Abortion Act becomes law, apart from in Northern Ireland, making termination legal up to 28 weeks if it is deemed to be in the best physical and mental interests of the patient. The world’s first test-tube baby, a girl called Louise Brown, is born on July 25 thanks to in vitro fertilization. The first advertising campaign in the fight against AIDS uses slogans such as “Don’t die of ignorance” to raise awareness. The world’s first heart, liver and lung transplant is  conducted in Cambridge. Free mammograms are offered in a bid to reduce breast cancer deaths among women over 50. The NHS Organ Donor Register is set up. More than 12 million people register by 2005, according to the NHS. A four-hour target for waiting times in hospital Accident and Emergency departments is made into an operational standard. The Care Quality Commission, a new regulator which will  monitor health services, is launched. Junior doctors in England go on their first all-out strike, protesting at government plans for a new employment contract.
answer:
Timeline: Britain's National Health Service turns 70.


question:
Pakistan is also the only polio-endemic country in the world where polio cases rose from 2012 to 2013, the statement said. There were 91 cases last year but only 58 the year before. Polio can permanently paralyze or kill victims within hours of infection. Intensive vaccination campaigns have almost eradicated the disease worldwide, but it remains endemic in Pakistan, Afghanistan and Nigeria. In Pakistan, Taliban commanders have forbidden vaccination teams access in some areas. A handful of religious leaders have also denounced the campaign as a plot to sterilize Muslim children. The rhetoric has fueled violence against the vaccination teams. Many teams travel only with police protection. Last year there were more than 30 attacks on polio teams. But Dr. Elias Durry, the head of the WHO’s polio eradication program in Pakistan, emphasized that campaigns in most parts of the country had been successful. “The virus has not been seen in all parts of Pakistan,” he said. “It’s in very limited areas that we have problems in accessing.”  Some of the attacks took place in Peshawar, the capital of northern Khyber Paktunkhwa province. The old city is a maze of shops and homes where open sewers run through the streets. The city is plagued by Taliban and sectarian violence. Many families fleeing the Taliban insurgency in the north seek refuge there. Peshawar’s huge, mobile population and poor sanitation make it an ideal incubating ground for the disease. More than 90 percent of Pakistani polio cases last year were linked to a strain of disease found in the Peshawar sewers. All but one of the 13 cases in Afghanistan were also linked to Peshawar, WHO said.
answer:
Pakistani city is world's biggest reservoir of polio viruses.


question:
UCB shares dropped as much as 18.4 percent to 21.60 euros,  their lowest level since August 2003, as investors took a dim  view of the latest in a series of setbacks to hit the group. This month, U.S. health officials warned its prescription  cough medicine Tussionex could be fatal for young children if  taken frequently, though it is not approved for those aged  under six. UCB has also yet to convince regulators its would-be  blockbuster Cimzia should be cleared for treating the bowel  disorder Crohn’s disease. The European Medicines Agency on  Thursday reaffirmed its view that Cimzia should not be  approved. Last year, UCB achieved net sales of 52 million euros  ($81.7 million) from Neupro, a relatively new product. “Depending on the resolution timeline of this issue, the  full effect on UCB’s business is not yet known. Therefore,  UCB’s 2008 financial outlook is under review and will be  updated as soon as possible,” the company said in a statement. UCB said the recall decision was not the result of  contamination or toxicity but that the clinical performance of  some samples on the market was not as required. “As a result, there will be an out-of-stock situation with  Neupro in the United States in late April 2008. In the European  Union and most other regions, Neupro supply is sufficient,” it  continued. A spokeswoman said it was not clear how long UCB would be  out of stock in the U.S. and likewise when it would be able to  give a new 2008 outlook. KBC Securities said in a research note it had reduced its  forecast for Neupro sales this year to 88 million euros from  110 million, as well as its peak annual sales estimates and cut  its target price to 33.50 euros from 35.00 euros. “This disruption comes at a crucial time in the launch  phase of this important franchise,” Deutsche Bank wrote, adding  Neupro’s launch for restless legs could be significantly  delayed by regulators’ insistence that quality problems be  resolved. Neupro, delivered to patients in the form of patches stuck  on the skin, is approved to treat early-stage Parkinson’s in  the U.S. and early and late stages of the disease in Europe. The patches were launched in Europe in 2006 and in the U.S.  in July 2007. It filed for approval to treat restless legs syndrome in  the United States and Europe in December. UCB last month forecast revenue would decrease to about 3.4  billion euros in 2008 from 3.6 billion last year. Recurring  core profit (EBITDA) would be about 650 million euros and net  profit was expected to exceed 100 million.
answer:

UCB recalls Parkinson's patch, reviews 2008 outlook.